Vietnam Ministry of Health Recalls More Indian Medicines

Vietnam are recalling two lots of antibiotics manufactured in India for not meeting quality standards, according to documents recently issued by the Department of Drug Management under the Ministry of Health, state media reported. The two drugs are Ceferaxim 125 (Cefuroxime 125mg), lot no. 173316001, with the expiry date of January 5, 2018 and registration No.VN-11733-11, manufactured by Vintanova Pharma Pvt. Ltd., and imported by Dai Nam Pharmaceutical Co. Ltd., and Rom-150 tablets (Roxithromycin 150mg), lot No.ZET1709, manufacturing date July 22, 2014 and expiry date July 21, 2017 with registration No.VN-17178-13 manufactured by Zee Laboratories and imported by Codupha Central Pharmaceutical JSC. A lot of antibiotics manufactured in Vietnam was also asked to be recalled, namely Philtadol (Cefpodoxim 100mg), lot No.15002, with the expiry date of November 3, 2017, registration No.VD-22044-14, produced by Korean company Phil Inter Pharma at its Vietnamese plant in Vietnam-Singapore industrial park in the southern province of Binh Duong. The decision to recall these drugs was based on tests performed by the National Institute of Drug Quality Control. India is one of the world’s major suppliers of pharmaceutical products and ingredients and the second largest supplier of these items in Vietnam, after France. (dantri.com.vn July 14, kinhtedothi.vn July 13)